Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Analyst Comment

Fireside chat - Pharma Equity Group - One pager

Pharma Equity Group

Fireside chat - Pharma Equity Group - One pager

Interview med senior analytiker Henrik Ekman. Vi gennemgår vores seneste One-pager på Pharma Equity Group.

Hvad er PEG for et selskab, Hvad er deres største aktiv i dag, hvordan adskiller PEG sig fra andre Life Science selskaber på børsen, hvordan ser pipelinen ud i Reponex og hvad anvender vi for værdisætning.

Lyt her: https://youtu.be/Ro3ETzmUC2M

Disclaimer:

HC Andersen Capital modtager betaling fra Pharma Equity Group for en Digital IR/Corporate Visibility abonnementsaftale. /ANALYTIKER Claus Thestrup  kl. 14:40 d. 15/6-2023.

Pharma Equity Group develops medicines for the treatment of serious and life-threatening inflammatory diseases for which there is currently no adequate treatment. The Company uses repositioning of existing medicines and takes drug candidates to a clinical Phase III stage, after which they are handed over to a strategic partner who will complete the development of the products and bring them to market, either independently or in collaboration with the Company.

Read more on company page
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.